Adel Boueiz1, Yale Chang2, Michael H Cho3, George R Washko3, Raul San José Estépar4, Russell P Bowler5, James D Crapo5, Dawn L DeMeo1, Jennifer G Dy2, Edwin K Silverman1, Peter J Castaldi6. 1. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Pulmonary and Critical Care Medicine Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 2. Department of Electrical and Computer Engineering, Northeastern University, Boston, MA. 3. Pulmonary and Critical Care Medicine Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 4. Surgical Planning Laboratory, Laboratory of Mathematics in Imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. 5. Division of Pulmonary Medicine, Department of Medicine, National Jewish Health, Denver, CO. 6. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Division of General Medicine and Primary Care, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: repjc@channing.harvard.edu.
Abstract
BACKGROUND: Emphysema has considerable variability in its regional distribution. Craniocaudal emphysema distribution is an important predictor of the response to lung volume reduction. However, there is little consensus regarding how to define upper lobe-predominant and lower lobe-predominant emphysema subtypes. Consequently, the clinical and genetic associations with these subtypes are poorly characterized. METHODS: We sought to identify subgroups characterized by upper-lobe or lower-lobe emphysema predominance and comparable amounts of total emphysema by analyzing data from 9,210 smokers without alpha-1-antitrypsin deficiency in the Genetic Epidemiology of COPD (COPDGene) cohort. CT densitometric emphysema was measured in each lung lobe. Random forest clustering was applied to lobar emphysema variables after regressing out the effects of total emphysema. Clusters were tested for association with clinical and imaging outcomes at baseline and at 5-year follow-up. Their associations with genetic variants were also compared. RESULTS: Three clusters were identified: minimal emphysema (n = 1,312), upper lobe-predominant emphysema (n = 905), and lower lobe-predominant emphysema (n = 796). Despite a similar amount of total emphysema, the lower-lobe group had more severe airflow obstruction at baseline and higher rates of metabolic syndrome compared with subjects with upper-lobe predominance. The group with upper-lobe predominance had greater 5-year progression of emphysema, gas trapping, and dyspnea. Differential associations with known COPD genetic risk variants were noted. CONCLUSIONS: Subgroups of smokers defined by upper-lobe or lower-lobe emphysema predominance exhibit different functional and radiological disease progression rates, and the upper-lobe predominant subtype shows evidence of association with known COPD genetic risk variants. These subgroups may be useful in the development of personalized treatments for COPD.
BACKGROUND:Emphysema has considerable variability in its regional distribution. Craniocaudal emphysema distribution is an important predictor of the response to lung volume reduction. However, there is little consensus regarding how to define upper lobe-predominant and lower lobe-predominant emphysema subtypes. Consequently, the clinical and genetic associations with these subtypes are poorly characterized. METHODS: We sought to identify subgroups characterized by upper-lobe or lower-lobe emphysema predominance and comparable amounts of total emphysema by analyzing data from 9,210 smokers without alpha-1-antitrypsin deficiency in the Genetic Epidemiology of COPD (COPDGene) cohort. CT densitometric emphysema was measured in each lung lobe. Random forest clustering was applied to lobar emphysema variables after regressing out the effects of total emphysema. Clusters were tested for association with clinical and imaging outcomes at baseline and at 5-year follow-up. Their associations with genetic variants were also compared. RESULTS: Three clusters were identified: minimal emphysema (n = 1,312), upper lobe-predominant emphysema (n = 905), and lower lobe-predominant emphysema (n = 796). Despite a similar amount of total emphysema, the lower-lobe group had more severe airflow obstruction at baseline and higher rates of metabolic syndrome compared with subjects with upper-lobe predominance. The group with upper-lobe predominance had greater 5-year progression of emphysema, gas trapping, and dyspnea. Differential associations with known COPD genetic risk variants were noted. CONCLUSIONS: Subgroups of smokers defined by upper-lobe or lower-lobe emphysema predominance exhibit different functional and radiological disease progression rates, and the upper-lobe predominant subtype shows evidence of association with known COPD genetic risk variants. These subgroups may be useful in the development of personalized treatments for COPD.
Authors: H O Coxson; R M Rogers; K P Whittall; Y D'yachkova; P D Paré; F C Sciurba; J C Hogg Journal: Am J Respir Crit Care Med Date: 1999-03 Impact factor: 21.405
Authors: Peter J Castaldi; Marta Benet; Hans Petersen; Nicholas Rafaels; James Finigan; Matteo Paoletti; H Marike Boezen; Judith M Vonk; Russell Bowler; Massimo Pistolesi; Milo A Puhan; Josep Anto; Els Wauters; Diether Lambrechts; Wim Janssens; Francesca Bigazzi; Gianna Camiciottoli; Michael H Cho; Craig P Hersh; Kathleen Barnes; Stephen Rennard; Meher Preethi Boorgula; Jennifer Dy; Nadia N Hansel; James D Crapo; Yohannes Tesfaigzi; Alvar Agusti; Edwin K Silverman; Judith Garcia-Aymerich Journal: Thorax Date: 2017-06-21 Impact factor: 9.139
Authors: Federico Venuta; Marco Anile; Daniele Diso; Carolina Carillo; Tiziano De Giacomo; Antonio D'Andrilli; Francesco Fraioli; Erino A Rendina; Giorgio F Coloni Journal: Eur Respir J Date: 2011-10-17 Impact factor: 16.671
Authors: Ani Manichaikul; Eric A Hoffman; Joanna Smolonska; Wei Gao; Michael H Cho; Heather Baumhauer; Matthew Budoff; John H M Austin; George R Washko; J Jeffrey Carr; Joel D Kaufman; Tess Pottinger; Charles A Powell; Cisca Wijmenga; Pieter Zanen; Harry J M Groen; Dirkje S Postma; Adam Wanner; Farshid N Rouhani; Mark L Brantly; Rhea Powell; Benjamin M Smith; Dan Rabinowitz; Leslie J Raffel; Karen D Hinckley Stukovsky; James D Crapo; Terri H Beaty; John E Hokanson; Edwin K Silverman; Josée Dupuis; George T O'Connor; H Marike Boezen; Stephen S Rich; R Graham Barr Journal: Am J Respir Crit Care Med Date: 2014-02-15 Impact factor: 21.405
Authors: James C Ross; Gordon L Kindlmann; Yuka Okajima; Hiroto Hatabu; Alejandro A Díaz; Edwin K Silverman; George R Washko; Jennifer Dy; Raúl San José Estépar Journal: Med Phys Date: 2013-12 Impact factor: 4.071
Authors: Adel Boueiz; Sharon M Lutz; Michael H Cho; Craig P Hersh; Russell P Bowler; George R Washko; Eitan Halper-Stromberg; Per Bakke; Amund Gulsvik; Nan M Laird; Terri H Beaty; Harvey O Coxson; James D Crapo; Edwin K Silverman; Peter J Castaldi; Dawn L DeMeo Journal: Am J Respir Crit Care Med Date: 2017-03-15 Impact factor: 21.405
Authors: Dawn L DeMeo; Craig P Hersh; Eric A Hoffman; Augusto A Litonjua; Ross Lazarus; David Sparrow; Joshua O Benditt; Gerard Criner; Barry Make; Fernando J Martinez; Paul D Scanlon; Frank C Sciurba; James P Utz; John J Reilly; Edwin K Silverman Journal: Am J Respir Crit Care Med Date: 2007-03-15 Impact factor: 21.405
Authors: Meilan K Han; Ella A Kazerooni; David A Lynch; Lyrica X Liu; Susan Murray; Jeffrey L Curtis; Gerard J Criner; Victor Kim; Russell P Bowler; Nicola A Hanania; Antonio R Anzueto; Barry J Make; John E Hokanson; James D Crapo; Edwin K Silverman; Fernando J Martinez; George R Washko Journal: Radiology Date: 2011-07-25 Impact factor: 11.105
Authors: Peter J Castaldi; Adel Boueiz; Jeong Yun; Raul San Jose Estepar; James C Ross; George Washko; Michael H Cho; Craig P Hersh; Gregory L Kinney; Kendra A Young; Elizabeth A Regan; David A Lynch; Gerald J Criner; Jennifer G Dy; Stephen I Rennard; Richard Casaburi; Barry J Make; James Crapo; Edwin K Silverman; John E Hokanson Journal: Chest Date: 2019-12-28 Impact factor: 9.410
Authors: Wassim W Labaki; Tian Gu; Susan Murray; Charles R Hatt; Craig J Galbán; Brian D Ross; Carlos H Martinez; Jeffrey L Curtis; Eric A Hoffman; Esther Pompe; David A Lynch; Ella A Kazerooni; Fernando J Martinez; MeiLan K Han Journal: Acad Radiol Date: 2018-07-26 Impact factor: 3.173
Authors: Wassim W Labaki; Tian Gu; Susan Murray; Charles R Hatt; Craig J Galbán; Brian D Ross; Carlos H Martinez; Jeffrey L Curtis; Eric A Hoffman; Esther Pompe; David A Lynch; Ella A Kazerooni; Fernando J Martinez; MeiLan K Han Journal: Acad Radiol Date: 2019-02-18 Impact factor: 3.173
Authors: Surya P Bhatt; George R Washko; Eric A Hoffman; John D Newell; Sandeep Bodduluri; Alejandro A Diaz; Craig J Galban; Edwin K Silverman; Raúl San José Estépar; David A Lynch Journal: Am J Respir Crit Care Med Date: 2019-02-01 Impact factor: 21.405
Authors: Sarah E Gerard; Taylor J Patton; Gary E Christensen; John E Bayouth; Joseph M Reinhardt Journal: IEEE Trans Med Imaging Date: 2018-08-10 Impact factor: 10.048
Authors: Jinkyeong Park; Brian D Hobbs; James D Crapo; Barry J Make; Elizabeth A Regan; Stephen Humphries; Vincent J Carey; David A Lynch; Edwin K Silverman Journal: Chest Date: 2019-07-05 Impact factor: 9.410
Authors: Bilal El Kaddouri; Matthew J Strand; David Baraghoshi; Stephen M Humphries; Jean-Paul Charbonnier; Eva M van Rikxoort; David A Lynch Journal: Radiology Date: 2020-12-15 Impact factor: 11.105
Authors: Wassim W Labaki; Meng Xia; Susan Murray; Charles R Hatt; Abdullah Al-Abcha; Michael C Ferrera; Catherine A Meldrum; Lauren A Keith; Craig J Galbán; Douglas A Arenberg; Jeffrey L Curtis; Fernando J Martinez; Ella A Kazerooni; MeiLan K Han Journal: Chest Date: 2020-12-14 Impact factor: 9.410